1. Home
  2. FSBW vs CTNM Comparison

FSBW vs CTNM Comparison

Compare FSBW & CTNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Bancorp Inc.

FSBW

FS Bancorp Inc.

HOLD

Current Price

$40.96

Market Cap

305.6M

Sector

Finance

ML Signal

HOLD

Logo Contineum Therapeutics Inc. Class A Common Stock

CTNM

Contineum Therapeutics Inc. Class A Common Stock

HOLD

Current Price

$12.45

Market Cap

328.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBW
CTNM
Founded
1936
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
305.6M
328.1M
IPO Year
2012
2024

Fundamental Metrics

Financial Performance
Metric
FSBW
CTNM
Price
$40.96
$12.45
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$44.00
$20.00
AVG Volume (30 Days)
13.8K
183.2K
Earning Date
01-20-2026
10-30-2025
Dividend Yield
2.73%
N/A
EPS Growth
N/A
N/A
EPS
4.09
N/A
Revenue
$140,954,000.00
N/A
Revenue This Year
$10.46
N/A
Revenue Next Year
$4.42
N/A
P/E Ratio
$10.03
N/A
Revenue Growth
1.07
N/A
52 Week Low
$34.61
$3.35
52 Week High
$46.20
$15.25

Technical Indicators

Market Signals
Indicator
FSBW
CTNM
Relative Strength Index (RSI) 64.54 62.14
Support Level $39.48 $10.42
Resistance Level $41.15 $13.00
Average True Range (ATR) 0.75 0.72
MACD 0.14 0.17
Stochastic Oscillator 100.00 83.13

Price Performance

Historical Comparison
FSBW
CTNM

About FSBW FS Bancorp Inc.

FS Bancorp Inc is the holding company of 1st Security Bank, a diversified lender with a focus on the origination of commercial real estate, one-to-four-family, and home equity loans, consumer loans, including a variety of indirect home improvement (fixture secured loans), and marine loans, and commercial business loans. The company has two operating segments; The commercial and consumer banking segment provides diversified financial products and services to its commercial and consumer customers through Bank branches, automated teller machines, online banking platforms, mobile banking apps, and telephone banking; and The home lending segment originates one-to-four-family residential mortgage loans for sale in the secondary markets as well as loans held for investment.

About CTNM Contineum Therapeutics Inc. Class A Common Stock

Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.

Share on Social Networks: